CAS 74050-97-8
:Haloperidol decanoate
Description:
Haloperidol decanoate is an antipsychotic medication primarily used in the treatment of schizophrenia and other psychotic disorders. It is an ester derivative of haloperidol, which is a butyrophenone antipsychotic. This compound is characterized by its long-acting formulation, allowing for extended therapeutic effects with less frequent dosing compared to its parent compound. Haloperidol decanoate is typically administered via intramuscular injection, providing a sustained release of the active drug into the bloodstream. The substance is known for its ability to alleviate symptoms of psychosis, including hallucinations and delusions, by antagonizing dopamine receptors in the brain. Its pharmacokinetics involve a gradual release and metabolism, which contributes to its prolonged action. Common side effects may include sedation, extrapyramidal symptoms, and potential metabolic changes. As with any medication, careful monitoring is essential to manage these effects and ensure patient safety. Overall, haloperidol decanoate plays a significant role in the management of chronic psychiatric conditions, offering a valuable option for long-term treatment.
Formula:C31H41ClFNO3
InChI:InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3
InChI key:InChIKey=GUTXTARXLVFHDK-UHFFFAOYSA-N
SMILES:O(C(CCCCCCCCC)=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
Synonyms:- 4-(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidyl decanoate
- 4-(4-Chlorophenyl)-1-[4-(4-Fluorophenyl)-4-Oxobutyl]Piperidin-4-Yl Decanoate
- Decanoic acid, 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl ester
- Decanoic acid, ester with 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
- Depot haloperidol
- Haldol decanoas
- Haldol decanoate
- Halomonth
- Haloperidol decanoate [USAN:BAN:JAN]
- Haloperidol depot
- Kd 136
- Kd 16
- Neoperidole
- R 13,672
- R 13762
- Unii-Ac20Pj4101
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
HALOPERIDOL DECANOATE CRS
CAS:<p>HALOPERIDOL DECANOATE CRS</p>Formula:C31H41ClFNO3Color and Shape:White. Powder.Molecular weight:530.1135Haloperidol Decanoate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C31H41ClFNO3Color and Shape:White Off-White PowderMolecular weight:529.2759Haloperidol Decanoate
CAS:Formula:C31H41ClFNO3Purity:99%Color and Shape:SolidMolecular weight:530.1135Haloperidol Decanoate
CAS:Controlled ProductFormula:C31H41ClFNO3Color and Shape:NeatMolecular weight:530.11Haloperidol decanoate
CAS:<p>Haloperidol decanoate (KD 16), an antipsychotic, treats schizophrenia and mood disorders as an intramuscular ester.</p>Formula:C31H41ClFNO3Purity:99.57% - 99.72%Color and Shape:SolidMolecular weight:530.11Haloperidol decanoate
CAS:Controlled Product<p>Haloperidol decanoate is a long-acting form of haloperidol, which is an antipsychotic medication. It has the ability to bind to the dopamine D2 receptors, which are implicated in schizophrenia. Haloperidol decanoate has been shown to have a statistically significant effect on locomotor activity and chronic oral toxicity. The pharmacokinetic properties of this drug are dose dependent. Haloperidol decanoate binds at high affinity to the α7 nicotinic acetylcholine receptor, which is associated with energy metabolism. Long-term efficacy studies have shown that it can be used for treatment of schizophrenia with minimal side effects.</p>Formula:C31H41ClFNO3Purity:95%Molecular weight:530.11 g/molHaloperidol Decanoate
CAS:Controlled Product<p>Applications Antidyskinetic; antipsychotic.<br>References Janicki, C.A., et al.: Anal. Profiles Drug Subs., 9, 341 (1980), Beresford, R., et al.: Drugs, 33, 31 (1987)<br></p>Formula:C31H41ClFNO3Color and Shape:NeatMolecular weight:530.11
